Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort
Author(s) -
Monika Hebeisen,
Regula Neuenschwander,
Almut Scherer,
Pascale Exer,
Ulrich Weber,
Giorgio Tamborrini,
Raphael Micheroli,
Lukas Wildi,
Pascal Zufferey,
Michael J. Nissen,
Peter M. Villiger,
Jürg Bernhard,
Axel Finckh,
Irene van der HorstBruinsma,
Joachim Sieper,
Robert Landewé,
Désirée van der Heijde,
Adrian Ciurea
Publication year - 2018
Publication title -
the journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.577
H-Index - 178
eISSN - 1499-2752
pISSN - 0315-162X
DOI - 10.3899/jrheum.170166
Subject(s) - medicine , ankylosing spondylitis , cohort , logistic regression , prospective cohort study , cohort study , spondylitis , physical therapy
To investigate sex differences in connection with the effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with ankylosing spondylitis (AS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom